As of November 2024, Regenicin has a market cap of $15.35K. This makes Regenicin the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $15.35K | 0.00% |
2023 | $15.35K | -80.00% |
2022 | $76.74K | -95.00% |
2021 | $1.53M | -33.99% |
2020 | $2.33M | 43.60% |
2019 | $1.62M | -33.65% |
2018 | $2.44M | -87.28% |
2017 | $19.19M | 8.70% |
2016 | $17.65M | 450.24% |
2015 | $3.21M | -27.93% |
2014 | $4.45M | -3.33% |
2013 | $4.60M | -64.29% |
2012 | $12.89M | 5.00% |
2011 | $12.28M | -86.67% |
2010 | $92.09M | -40.59% |
2009 | $155.02M | - |